Results 171 to 180 of about 875,209 (309)

Understanding the role of overdose witnesses: responses and characteristics of people who inject drugs in Oakland and San Francisco. [PDF]

Harm Reduct J
Suprasert B, Ruiz R, Francisco J, Lella P, O'Neal IR, Velasquez G, Baguso GN, Santos GM, Wilson EC, Dunne EF, McFarland W.   +10 more
europepmc   +1 more source

“The Most Difficult Conversations We Have”: Resident Experiences With Pediatric Neuroprognostication

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Pediatric neuroprognostication is often complicated by uncertainty and embedded in high‐stakes medical decisions. For child neurology residents, participation in neuroprognostication can represent key learning experiences but also comes with emotional and ethical challenges, which poses a risk of moral distress.
Grant L. Lin, Beatrice D. White, Shelby D. Burk, Jessica A. Moriarty, David B. Mauser, Claire E. Wakefield, Courtney J. Wusthoff, Justin N. Baker   +7 more
wiley   +1 more source

Association of Gonioscopy Scores with Changes in Intraocular Pressure after Phacoemulsification in a Predominantly Vietnamese Population: A Retrospective Study

Clinical Ophthalmology
Kelly C Nguyen,1 Sunee Chansangpetch,2– 4 Dzuy Truong,5 Brittney G Tran,6 Lauren Nguyen,6 Ngoc Nguyen,7 Andrew Iwach,8,9 Shan C Lin7,8 1University of California, San Francisco School of Medicine, San Francisco, CA, USA; 2Faculty of Medicine ...
Nguyen KC, Chansangpetch S, Truong D, Tran BG, Nguyen L, Nguyen N, Iwach A, Lin SC   +7 more
doaj  

A comparison of opioid overdose risk behaviors by race and ethnicity among overdose survivors in Boston, MA, and San Francisco, CA. [PDF]

Harm Reduct J
Reed GE, McMahan VM, Chang YG, Johnson NL, Walley AY, Coffin PO, Harris MTH.   +6 more
europepmc   +1 more source

The Visual Predictive Check and Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
The visual predictive check (VPC) is a standard tool for assessing pharmacometric model suitability, producing visualizations that compare observed data with simulated data such that both model structure and model variability terms can be assessed. However, real‐world data commonly reflect clinical decision‐making that adapts therapy in response to ...
Jasmine H. Hughes, Martin Bergstrand, Ron J. Keizer   +2 more
wiley   +1 more source

Eye and Orbit Injuries Caused by Electric Scooters and Hoverboards in the United States

Clinical Ophthalmology
Merry ZC Ruan,1,2 Elana Meer,1,2 Gurbani Kaur,2 Nikan K Namiri,2 Davin C Ashraf,3 Bryan J Winn,1,4 Robert Kersten,1,4 M Reza Vagefi,1,4 Seanna Grob1,4 1Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA ...
Ruan MZ, Meer E, Kaur G, Namiri NK, Ashraf DC, Winn BJ, Kersten R, Vagefi MR, Grob S   +8 more
doaj  

Evaluation of an oral health program for children in San Francisco de Macorís, Dominican Republic (2019-2024). [PDF]

Front Oral Health
Ribas-Perez D, Muñoz-Viveros C, Formoso-Veloso AL, Jesus Carrillo-Sanchez F, Castaño-Seiquer A.   +4 more
europepmc   +1 more source

Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis

Clinical Pharmacology &Therapeutics, EarlyView.
In patients with systemic lupus erythematosus (SLE), increased type I interferon signaling is associated with increased disease activity across organs, including in the kidney, which can cause lupus nephritis (LN). Anifrolumab, which abrogates type I interferon signaling, is an approved treatment for moderate to severe SLE.
Joachim Almquist, Yen Lin Chia, Raj Tummala, Lynn Bertagnolli, David Jayne, Weifeng Tang, Catharina Lindholm   +6 more
wiley   +1 more source

Time-varying flow-ecology relationships for an endangered fish population: Longfin Smelt in the San Francisco Estuary. [PDF]

Ecol Appl
Saffarinia P, Hobbs JA, Carlson SM, Ruhí A.   +3 more
europepmc   +1 more source

Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative

Clinical Pharmacology &Therapeutics, EarlyView.
The Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation (CARE) Initiative seeks to advance understanding of when real‐world data (RWD) can generate valid treatment effectiveness estimates by emulating completed oncology randomized controlled trials (RCTs).
Natalie Levy, Paige Sheridan, Ulka Campbell, David Lenis, Inish O'Doherty, Adina Estrin, Nileesa Gautam, Monica Iyer, Sarah McDonald, Andrew Belli, Gillis Carrigan, K. Arnold Chan, James Chen, Victoria Chia, Neil Dhopeshwarkar, Joy Eckert, Laura Fernandes, Joel Greshock, Rachele Hendricks‐Sturrup, Jenny Huang, XiaoLong Jiao, Sajan Khosla, Orsolya Lunacsek, Lynn McRoy, Yanina Natanzon, Osayi Ovbiosa, Nelson Pace, Simone Pinheiro, Megan Rees, Jennifer Rider, Mothaffar Fahed Rimawi, Travis Robinson, Carla Rodriguez‐Watson, Chithra Sangli, Khaled Sarsour, Sebastian Schneeweiss, Mark Shapiro, Mark Stewart, Aliki Taylor, C. K. Wang, Shirley Wang, Yiduo Zhang, Ann Madsen   +42 more
wiley   +1 more source